Inter-method variability in PTH measurement: implication for the care of CKD patients.
作者： J.-C. Souberbielle , A. Boutten , M.-C. Carlier , D. Chevenne , G. Coumaros
关键词:
摘要: … As these limits were derived from studies that used the Allegro intact PTH assay, we aimed to evaluate whether they were applicable to other PTH assays. We compared the PTH …
kidney-international.org
core.ac.uk
nature.com
sci-hub.se 参考文章(31)
P.J.M. Wakkers, H.B.A. Hellendoorn, G.J.Op De Weegh, W. Heerspink, Applications of statistics in clinical chemistry Clinica Chimica Acta. ,vol. 64, pp. 173- 184 ,(1975) , 10.1016/0009-8981(75)90199-0
Raymond Lepage, Louise Roy, Jean-Hugues Brossard, Louise Rousseau, Claude Dorais, Claude Lazure, Pierre D’Amour, A non-(1–84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples Clinical Chemistry. ,vol. 44, pp. 805- 809 ,(1998) , 10.1093/CLINCHEM/44.4.805
Jean-Hugues Brossard, Raymond Lepage, Héloïse Cardinal, Louise Roy, Louise Rousseau, Claude Dorais, Pierre D’Amour, Influence of Glomerular Filtration Rate on Non-(1-84) Parathyroid Hormone (PTH) Detected by Intact PTH Assays Clinical Chemistry. ,vol. 46, pp. 697- 703 ,(2000) , 10.1093/CLINCHEM/46.5.697
Isidro B. Salusky, William G. Goodman, Beatriz D. Kuizon, Jeffrey R. Lavigne, Richard J. Zahranik, Barbara Gales, He-Jing Wang, Robert M. Elashoff, Harald Jüppner, Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis Kidney International. ,vol. 63, pp. 1801- 1808 ,(2003) , 10.1046/J.1523-1755.2003.00915.X
Gavril Hercz, Y. Pei, C. Greenwood, A. Manuel, C. Saiphoo, W.G. Goodman, G.V. Segre, S. Fenton, D.J. Sherrard, Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid function Kidney International. ,vol. 44, pp. 860- 866 ,(1993) , 10.1038/KI.1993.323
Philippe Boudou, Fidaa Ibrahim, Catherine Cormier, Almécinda Chabas, Emile Sarfati, Jean-Claude Souberbielle, Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. ,vol. 90, pp. 6370- 6372 ,(2005) , 10.1210/JC.2005-0715
Pierre DʼAmour, Jean-Hugues Brossard, Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology Current Opinion in Nephrology and Hypertension. ,vol. 14, pp. 330- 336 ,(2005) , 10.1097/01.MNH.0000172718.49476.64
Donald J. Sherrard, Gavril Hercz, York Pei, Norma A. Maloney, Celia Greenwood, Arif Manuel, Carl Saiphoo, Stanley S. Fenton, Gino V. Segre, The spectrum of bone disease in end-stage renal failure—An evolving disorder Kidney International. ,vol. 43, pp. 436- 442 ,(1993) , 10.1038/KI.1993.64
G K Worth, S D Vasikaran, R W Retallack, A A Musk, D H Gutteridge, Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure. Annals of Clinical Biochemistry. ,vol. 41, pp. 149- 154 ,(2004) , 10.1258/000456304322880050
Kevin J. Martin, Harald Juppner, Donald J. Sherrard, William G. Goodman, Mark R. Kaplan, George Nassar, Patricia Campbell, Mario Curzi, Chaim C. Harytan, Laura C. Mccary, Matthew D. Guo, Stewart A. Turner, David A. Bushinsky, First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney International. ,vol. 68, pp. 1236- 1243 ,(2005) , 10.1111/J.1523-1755.2005.00517.X